As
per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that the Company has arranged earnings conference call on Monday, 31 January 2022 at 2:00 pm (IST) to discuss the standalone and consolidated unaudited financial results of the Company for the quarter and nine months ended 31 December 2021.
The above information is a part of company’s filings submitted to BSE.